Intensive blood pressure control in hospitalized older adults beneficial or detrimental?
NSMC intern Melvin Chan explains with a visual abstract
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every big nephrology congress. Probably 1st place won’t surprise anyone; it was the anticipated FLOW of the year, but this Top 10 Nephrology Stories definitely includes some unexpected titles
Intensive blood pressure control in hospitalized older adults beneficial or detrimental?
NSMC intern Melvin Chan explains with a visual abstract
Patients are given a lot of fluid post-transplant, but which to choose? Catch up on the latest evidence here.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) August 4, 2023
✳️10 tweets #NephJC catch-up ✳️
One of kidney transplantation's 1st & greatest challenges is delayed graft function (DGF) - 20-30%. In postop, trembling, weak evidence shows balance could be attained, but no fluid cure
What's BEST (fluid) solution? pic.twitter.com/3ocSa4AmtV
Huge trial on our core work, catch-up here
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) July 31, 2023
✳️10 tweets #NephJC catch-up ✳️
🌟Let’s recap the CONVINCE trial which pitted HDF against HD
🌟Do we now have CONVINCE-ing evidence for the superiority of convection added to diffusion? pic.twitter.com/92gW0zKv76
Is intravenous fluid therapy with a balanced crystalloid solution better than saline for patients receiving a deceased donor kidney transplant? Check out the BEST-FLUID VA by NSMC Intern Anitha Swami
Sorry, you missed it.
Purchasing a Golden Flozinator pin will also give you a ticket to the NephJC Live Podcast recording with the Curbsiders at this year’s ASN Kidney Week.
Check out the COVINCE-ing Visual Abstract by Saumya Vishnoi
WIth no RCTs to go on, we review a meta-analysis on sodium thiosulphate for calciphylaxis
1/10
— Nephrology Journal Club (@NephJC) June 30, 2023
Welcome to #TenTweetNephJC
Calciphylaxis is a rare but grim complication of ESKD & everyone wants to throw the kitchen sink at treating it.
A key part of treatment is sodium thiosulphate - but does it work?
Catch up on #NephJC reviewing biggest meta-analysis to date🧵👇 pic.twitter.com/LpXU9NupUa
Checkout this VA by NSMC Intern Brammah R. Thangarajah to understand the role of Sodium Thiosulphate in Calciphylaxis
RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) June 16, 2023
We bring to you today a treatment suggested (2B) by KDIGO to be beneficial in slowing eGFR decline of non-Transplant patients, and evaluate its evidence in the Tx cohort.
Does NaHCO3 Preserve-Transplant function? 🧵
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/vSgmerzo2o
NephJC will be out in force at Kidney Week in Philadelphia this year. And the thing we are most excited about is the Friday night party (November 3rd) at Philadelphia City Winery. This year it is a two parter…
From 7 to 9 we will be doing a live recording of a special podcast with The Curbsiders! We will have some special guests in addition to Matt Watto and Paul Williams. It is going to be awesome. Seating is limited so you will need a ticket. To get a ticket you need to donate $100 to NephJC. The donation is tax-deductible in the US. The podcast recording includes an open bar and will likely have light appetizers (let’s see how the fund raising goes).
After the podcast we will have our traditional bar night “Blogger Night” at the same location from 9 until they toss us out. This will be a cash bar.